Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Law RJ, Gur-Arie L, Rosenshine I, Finlay BB.

Cold Spring Harb Perspect Med. 2013 Mar 1;3(3):a009977. doi: 10.1101/cshperspect.a009977. Review.

2.

Exploitation of host cells by enteropathogenic Escherichia coli.

Vallance BA, Finlay BB.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8799-806. Review.

3.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

4.

Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.

Calderon Toledo C, Arvidsson I, Karpman D.

Infect Immun. 2011 Jun;79(6):2224-33. doi: 10.1128/IAI.01024-10. Epub 2011 Mar 14.

5.

Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL.

Mol Microbiol. 2011 Jun;80(6):1420-38. doi: 10.1111/j.1365-2958.2011.07661.x. Epub 2011 May 5. Review.

6.

Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

Crane JK, Naeher TM, Broome JE, Boedeker EC.

Infect Immun. 2013 Apr;81(4):1129-39. doi: 10.1128/IAI.01124-12. Epub 2013 Jan 22.

7.

Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides.

Thomassin JL, Brannon JR, Kaiser J, Gruenheid S, Le Moual H.

Gut Microbes. 2012 Nov-Dec;3(6):556-61. doi: 10.4161/gmic.21656. Epub 2012 Aug 16. Review.

8.

Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging.

Rhee KJ, Cheng H, Harris A, Morin C, Kaper JB, Hecht G.

Gut Microbes. 2011 Jan-Feb;2(1):34-41. doi: 10.4161/gmic.2.1.14882.

9.

Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.

Santos AS, Finlay BB.

Cell Microbiol. 2015 Mar;17(3):318-32. doi: 10.1111/cmi.12412. Epub 2015 Feb 4. Review.

PMID:
25588886
10.

Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Kleta S, Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, Oelschlaeger TA, Bleiss W, Schierack P.

Infect Immun. 2014 May;82(5):1801-12. doi: 10.1128/IAI.01431-13. Epub 2014 Feb 18.

11.

The rise and rise of enteropathogenic Escherichia coli.

Robins-Browne RM.

S Afr Med J. 2007 Nov;97(11 Pt 3):1182-6.

PMID:
18250933
12.

Development of a multiplex PCR assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains.

Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG.

Front Cell Infect Microbiol. 2012 Feb 14;2:8. doi: 10.3389/fcimb.2012.00008. eCollection 2012.

13.

LEEways: tales of EPEC, ATEC and EHEC.

Schmidt MA.

Cell Microbiol. 2010 Nov;12(11):1544-52. doi: 10.1111/j.1462-5822.2010.01518.x. Epub 2010 Aug 31. Review.

PMID:
20716205
15.

[Molecular pathogenesis, epidemiology and diagnosis of enteropathogenic Escherichia coli].

Vidal JE, Canizález-Román A, Gutiérrez-Jiménez J, Navarro-García F.

Salud Publica Mex. 2007 Sep-Oct;49(5):376-86. Review. Spanish.

17.

Bacterial and host determinants of MAL activation upon EPEC infection: the roles of Tir, ABRA, and FLRT3.

Heath RJ, Leong JM, Visegrády B, Machesky LM, Xavier RJ.

PLoS Pathog. 2011 Apr;7(4):e1001332. doi: 10.1371/journal.ppat.1001332. Epub 2011 Apr 7.

18.

Oral infection with enteropathogenic Escherichia coli triggers immune response and intestinal histological alterations in mice selected for their minimal acute inflammatory responses.

Vulcano AB, Tino-De-Franco M, Amaral JA, Ribeiro OG, Cabrera WH, Bordenalli MA, Carbonare CB, Álvares EP, Carbonare SB.

Microbiol Immunol. 2014 Jun;58(6):352-9. doi: 10.1111/1348-0421.12153.

19.

Attaching-effacing Escherichia coli infections in cattle.

Moxley RA, Smith DR.

Vet Clin North Am Food Anim Pract. 2010 Mar;26(1):29-56, table of contents. doi: 10.1016/j.cvfa.2009.10.011.

PMID:
20117541
20.

The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.

Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, Sham HP, Vallance BA, Foster LJ, Finlay BB.

Cell Microbiol. 2010 Sep 1;12(9):1322-39. doi: 10.1111/j.1462-5822.2010.01470.x. Epub 2010 Mar 31.

PMID:
20374249
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk